Fontenay aux Roses, France

Cecile Combeau


Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Fontenay aux Roses, FR (2009 - 2012)
  • Paris, FR (2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Cecile Combeau

Introduction

Cecile Combeau is a notable inventor based in Fontenay aux Roses, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. With a total of 6 patents to her name, her work has the potential to impact cancer treatment significantly.

Latest Patents

One of Cecile Combeau's latest patents is focused on an anti-cancer compound and pharmaceutical composition. This invention relates to a compound of formula (I), specifically in its levorotatory form (1a). The compound exhibits a rotatory power of [α]D=−38.6+0.7 at a concentration of 0.698 mg/ml in methanol. It can exist as either a base or an acid addition salt, particularly a pharmaceutically acceptable acid. This compound serves as a selective Aurora A and B kinase inhibitor, making it a promising candidate for use as an anticancer drug.

Career Highlights

Cecile Combeau has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Sanofi. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Throughout her career, Cecile has collaborated with esteemed colleagues such as Jean-Christophe Carry and Francois Clerc. These partnerships have likely enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Cecile Combeau's innovative work in developing anti-cancer compounds showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her commitment to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…